source
- SystImmune/BMS and Hengrui showcase ADC data for EGFR-mutant lung cancer at ESMOAt the European Society for Medical Oncology (ESMO) meeting in Madrid, Li Zhang of Sun Yat-sen University Cancer Center presented early data from the HERON‑Lung01 study, highlighting an antibody‑dr…
- Australian clinical trials attract more U.S. sponsors amid regulatory uncertaintyCROs are reporting faster startup timelines, predictable regulation, and tax incentives as reasons for increasing interest in conducting clinical trials in Australia. State-level incentives in Que…